CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 13 enrolled
Drug / intervention
Propofol +1 moredrug
Likely dose
Propofol 4 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00830843
NCT00830843Phase 4Completed
CompareCT.gov

Inhalatorial Sedation in Patient With SAH Versus Conventional Intravenous Sedation (GAS-SAH)

Azienda Ospedaliera San Gerardo di Monza·interventional·Posted Jan 28, 2009·Updated Aug 22, 2016

In Brief

A Phase 4 clinical trial evaluating Propofol and Isoflurane for Stroke and Subarachnoid Hemorrhage. Completed, enrolled 13 participants across 1 site.

Detailed Summary

Recent study has shown that inhalatory sedation is a practicable, effective and not risky method in Intensive Care Unit. Sevoflurane effect on cerebral system have been described in previous studies: it causes an increasing of cerebral blood flow and a decrease of oxygen cerebral consumption. Clinical strategy for Subarachnoid Hemorrhage is orientated to increase cerebral blood flow to limit vasospasm phenomena after SAH. Scope of this study is to evaluate the Cerebral Blood Flow variation associated to Isoflurane sedation versus conventional sedation with propofol .

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Subarachnoid Hemorrhage
CountriesItaly
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 28, 2009
Enrollment StartJan 1, 2009
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 17.4 years ago

Interventions

Propofoldrug

Propofol(3-4 mg/kg/ora)administrated for 2 hours.

Isofluranedrug

Isoflurane inhalatorial administration for 2 hours at 0.8-1.0% Minimum Alveolar Concentration